Eli Lilly, which makes Zepbound and Mounjaro, reports that in a phase one clinical trial, a once daily GLP-1 pill helped lower the hemoglobin A1C, a measure of blood sugar control, in people with type ...

New research released Thursday morning shows a new, oral GLP-1 pill may be just as beneficial to those with Type 2 diabetes as injectable GLP-1 drugs. Drugmaker Eli Lilly said that in Phase 3 ...

The pharma giant said its oral GLP-1 drug demonstrated significant efficacy results and a safety profile consistent with its ...

Lilly, known for injectable drugs like Zepbound for obesity and Mounjaro and Trulicity for diabetes, is among several ...

Results from late-stage clinical trials suggest the GLP-1 pill orforglipron could be a promising alternative to injectable GLP-1 drugs like Ozempic. A late-stage clinical trial showed a new daily ...

A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...

The pill version could help more people around the world who don’t have easy access to refrigeration. It may also be easier to produce in large amounts. Lilly’s injectable GLP-1 drug went into ...

But drug manufacturers and researchers recognize the perks of pills. An oral version of these drugs—which are known as glucagon-like peptide 1 (GLP-1) receptor agonists—could be more ...